Want to see TSE:L full AI Analyst Report?
L Stock Chart & Stats
C$64.35
C$0.80(1.24%)
At close: 4:00 PM EDT
C$64.35
C$0.80(1.24%)
Day’s Range― - ―
52-Week RangeC$52.92 - C$69.59
Previous CloseN/A
Volume240.16K
Average Volume (3M)1.32M
Market Cap
C$70.01B
Enterprise ValueC$90.68K
Total Cash (Recent Filing)C$1.01B
Total Debt (Recent Filing)C$16.58B
Price to Earnings (P/E)25.3
Beta0.09
Next Earnings
Nov 18, 2026EPS Estimate
0.74Next Dividend Ex-DateN/A
Dividend Yield0.96%
Share Statistics
EPS (TTM)2.39
Shares Outstanding1,156,622,400
10 Day Avg. Volume1,517,649
30 Day Avg. Volume1,319,208
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)6.68
Price to Sales (P/S)1.15
P/FCF Ratio17.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$71.40Price Target Upside10.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.56
Revenue Forecast (FY)C$65.54B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue And Earnings GrowthSteady sales growth alongside faster EBITDA and EPS expansion indicates operating leverage and resilient execution. Improving profitability supports management’s high-single-digit earnings outlook over the next several quarters.
Pharmacy Growth And Healthcare DemandPharmacy and healthcare services provide a relatively defensive demand base and are expanding faster than the broader business. Prescription growth, specialty drugs and higher prescription values can support durable sales and profit momentum.
Strong Cash Generation And Reinvestment CapacityStrong cash generation gives Loblaw flexibility to fund store expansion, distribution automation and shareholder returns without relying exclusively on external financing. These investments can improve scale, fulfillment and long-term operating efficiency.
Bears Say
Meaningful Leverage Limits Financial FlexibilityLeverage remains significant for a defensive retailer, even after recent improvement. Higher debt can constrain investment and shareholder-return flexibility, while increasing sensitivity to interest costs or weaker consumer spending over the medium term.
Thin Margins Provide Limited Cost ProtectionGrocery retail’s structurally low net margin leaves limited room to absorb wage, freight, fuel or supplier-cost inflation. Sustaining earnings growth therefore depends on continued productivity, pricing discipline and favorable product mix.
Persistent Value Competition And Pricing PressureValue-focused shoppers and aggressive competitors can require sustained promotions and price investment, pressuring margins and brand economics. Loblaw’s scale and private labels help defend position, but execution must remain strong to preserve profitability.
Loblaw Companies News
L FAQ
What was Loblaw Companies’s price range in the past 12 months?
Loblaw Companies lowest stock price was C$52.92 and its highest was C$69.59 in the past 12 months.
What is Loblaw Companies’s market cap?
Loblaw Companies’s market cap is C$70.01B.
When is Loblaw Companies’s upcoming earnings report date?
Loblaw Companies’s upcoming earnings report date is Nov 18, 2026 which is in 86 days.
How were Loblaw Companies’s earnings last quarter?
Loblaw Companies released its earnings results on Jul 30, 2026. The company reported C$0.66 earnings per share for the quarter, beating the consensus estimate of C$0.648 by C$0.012.
Is Loblaw Companies overvalued?
According to Wall Street analysts Loblaw Companies’s price is currently Undervalued.
Does Loblaw Companies pay dividends?
Loblaw Companies pays a Quarterly dividend of C$0.155 which represents an annual dividend yield of 0.96%. See more information on Loblaw Companies dividends here
What is Loblaw Companies’s EPS estimate?
Loblaw Companies’s EPS estimate is 0.74.
How many shares outstanding does Loblaw Companies have?
Loblaw Companies has 1,156,622,400 shares outstanding.
What happened to Loblaw Companies’s price movement after its last earnings report?
Loblaw Companies reported an EPS of C$0.66 in its last earnings report, beating expectations of C$0.648. Following the earnings report the stock price went down -0.5%.
Which hedge fund is a major shareholder of Loblaw Companies?
Currently, no hedge funds are holding shares in TSE:L
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Loblaw Companies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$71.40 (10.96% Upside)
C$71.40 (10.96% Upside)
Blogger Sentiment
Bullish
TSE:L Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth C$8.6M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.59%
12-Months-Change
Fundamentals
Return on Equity
0.96%
Trailing 12-Months
Asset Growth
-0.82%
Trailing 12-Months
Company Description
Loblaw Companies
Loblaw Companies Limited is a prominent Canadian enterprise primarily focused on food and pharmacy, delivering a wide array of products and services across the nation. Its diverse business interests encompass grocery, pharmacy, health and beauty, apparel, general merchandise, financial services, and wireless mobile communications. The company structures its operations into two main divisions: Retail and Financial Services. The Retail division manages an extensive network of corporate and franchise food stores, in addition to associate-owned drugstores, which also house in-store pharmacies, dedicated health and beauty outlets, apparel shops, and various general merchandise locations. Conversely, the Financial Services segment provides credit card and banking solutions, manages the popular PC Optimum loyalty program, offers insurance brokerage, and delivers telecommunication services. Furthermore, Loblaw offers the PC Health app, a digital platform designed to connect Canadians with valuable healthcare resources and support. Established in 1919 and headquartered in Brampton, Canada, the company markets its offerings under numerous brands and functions as a subsidiary of George Weston Limited.
L Company Deck
L Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized broad operational strength: solid revenue and adjusted EPS growth, improving adjusted EBITDA, robust pharmacy momentum, strong e-commerce expansion, successful store openings (including an exceptionally strong T&T California debut), and a strengthened capital-return program. Management also highlighted positive early signs from GLP-1 generics as a potential gross margin tailwind. Near-term negatives were acknowledged but appear manageable: ramp costs for new distribution capacity and stores, some category/timing headwinds (Easter shift, tobacco/liquor, tariff timing), a one-month reporting timing impact from the PC Financial sale, and external risks like fuel-price volatility. Overall, the positives and strategic tailwinds substantially outweigh the manageable short-term headwinds.View all TSE:L earnings summariesL Stock 12 Month Forecast
Average Price Target
C$71.40
▲(10.96% Upside)